The safety of early versus late ambulation in the management of patients after percutaneous coronary interventions: A meta-analysis

被引:12
|
作者
Tongsai, Sasima [1 ]
Thamlikitkul, Visanu [1 ]
机构
[1] Mahidol Univ, Siriraj Hosp, Fac Med, Off Res & Dev,Clin Epidemiol Unit, Bangkok 10700, Thailand
关键词
Bed rest; Bleeding; Early ambulation; Late ambulation; Haematoma; Percutaneous coronary intervention; Meta-analysis; IMMEDIATE SHEATH REMOVAL; SAME-DAY DISCHARGE; GUIDING CATHETERS; PUBLICATION BIAS; FEMORAL ACCESS; ANGIOGRAPHY; ANGIOPLASTY; OUTCOMES; STAY; FILL;
D O I
10.1016/j.ijnurstu.2012.03.012
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Objective: Early ambulation after percutaneous coronary intervention (PCI) could increase patient comfort, decrease length of hospital stay, and reduce the costs. However, this approach may increase the risk of vascular complications and has not been well assessed. This study was conducted to assess the safety of early ambulation versus late ambulation by combining the study results on safety in patients undergoing PCI. Materials and methods: Studies were identified via five electronic databases, hand search and grey literature databases up to December 2011. We performed a meta-analysis of five randomized controlled trials to compare the safety of early versus late ambulation in the treatment of cardiac patients undergoing PCI. Of 1854 patients, 1083 were assigned to an early ambulation (range: 2-4 h of bed rest time) and 771 were assigned to late ambulation (range: 6-10 h of bed rest time). Results: There was no evidence that early ambulation was more harmful than late ambulation in terms of haematoma or bleeding event. The pooled relative risk (RR) of haematoma was 0.82 (95% CI, 0.53-1.28) and bleeding, 1.77 (95% CI, 0.87-3.59). A funnel plot showed minimal evidence of publication bias for haematoma event. Conclusions: The results of this first meta-analysis indicated that early ambulation after PCI was not associated with an increased risk of haematoma or bleeding. This study also confirmed the findings of the included studies recommending reducing the bed rest time from 6-10 h to 2-4 h after removal of the arterial sheath, and supporting early mobilization. (C) 2012 Elsevier Ltd. All rights reserved.
引用
下载
收藏
页码:1084 / 1090
页数:7
相关论文
共 50 条
  • [31] Meta-Analysis of Oral Anticoagulants with Dual versus Single Antiplatelet Therapy in Patients after Percutaneous Coronary Intervention
    Briasoulis, Alexandros
    Papageorgiou, Nikolaos
    Zacharia, Efimia
    Palla, Mohan
    El Abdallah, Mohamad Darwich
    Androulakis, Emmanuel
    Tousoulis, Dimitris
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2016, 16 (02) : 103 - 110
  • [32] Drug-eluting stents versus bare metal scents in percutaneous coronary interventions (a meta-analysis)
    Indolfi, C
    Pavia, M
    Angelillo, IF
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (10): : 1146 - 1152
  • [33] Efficacy and safety of bivalirudin versus heparin in patients undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials
    Zhang, Shuo
    Gao, Weihua
    Li, Haixia
    Zou, Meijuan
    Sun, Sihao
    Ba, Yijie
    Liu, Yang
    Cheng, Gang
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 209 : 87 - 95
  • [34] Bivalirudin versus heparin in percurtaneous coronary interventions: A meta-analysis
    Ebrahimi, R
    Lincoff, AM
    Shah, AP
    Bittl, JA
    Chew, D
    Wolski, K
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 36A - 37A
  • [35] Meta-analysis of bivalirudin versus heparin in transradial coronary interventions
    Kheiri, Babikir
    Rao, Sunil V.
    Osman, Mohammed
    Simpson, Timothy F.
    Barbarawi, Mahmoud
    Zayed, Yazan
    Dhillon, Harsukh N.
    Alkhouli, Mohamad
    Golwala, Harsh
    Zahr, Firas
    Bhatt, Deepak L.
    Stone, Gregg W.
    Cigarroa, Joaquin E.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2020, 96 (06) : 1240 - 1248
  • [36] Controlled comparison of early versus late ambulation after femoral sheath removal in coronary angioplasty
    Schiks, IE
    Nogarede-Hoekstra, J
    Aengevaeren, WRM
    Verheugt, FWA
    Van Achterberg, T
    EUROPEAN HEART JOURNAL, 2004, 25 : 24 - 24
  • [37] Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis
    Gelbenegger, Georg
    Schoergenhofer, Christian
    Jilma, Bernd
    Gager, Gloria M.
    Dizdarevic, Al Medina
    Mamas, Mamas A.
    Parapid, Biljana
    Velagapudi, Poonam
    Siller-Matula, Jolanta M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (02) : 424 - 431
  • [38] Safety of Early Discharge Among Low-Risk Patients After Primary Percutaneous Coronary Intervention: An Updated Systematic Review and Meta-Analysis
    Sugiharto, Firman
    Trisyani, Yanny
    Nuraeni, Aan
    Songwathana, Praneed
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2024, 20 : 169 - 183
  • [39] Drug eluting balloon versus drug eluting stent in percutaneous coronary interventions: Insights from a meta-analysis of 1462 patients
    Lupi, Alessandro
    Rognoni, Andrea
    Secco, Gioel Gabrio
    Porto, Italo
    Nardi, Federico
    Lazzero, Maurizio
    Rossi, Lidia
    Parisi, Rosario
    Fattori, Rossella
    Genoni, Giulia
    Rosso, Roberta
    Stella, Pieter R.
    Sheiban, Imad
    Bolognese, Leonardo
    Liistro, Francesco
    Bongo, Angelo Sante
    Agostoni, Pierfrancesco
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (05) : 4608 - 4616
  • [40] Meta-analysis of high-dose single-bolus tirofiban versus abciximab in patients undergoing percutaneous coronary interventions
    Dawson, C. B.
    Valgimigli, Marco
    Charnigo, Richard
    Walters, Darren L.
    Danzi, Gian B.
    Bolognese, Leonardo
    Moliterno, David J.
    Topol, Eric J.
    CIRCULATION, 2006, 114 (18) : 647 - 647